Ludovic Helfgott/LinkedIn
Mar 11, 2026, 14:54
Ludovic Helfgott: Grateful for Generosity in Supporting Patients with Hemophilia and Hemoglobinopathies
Ludovic Helfgott, Executive Vice President, Product and Portfolio Strategy at Novo Nordisk, shared a post on LinkedIn:
“One of the most gratifying things in the life of a Chairman of a not-for-profit organization is to take money directly from the pockets of your great colleagues and friends …for a good cause …and still see them smile afterwards.
Thanks to Maziar Mike Doustdar, Martin Holst Lange, Kasper Bødker Mejlvang, Habib Bennaceur (and many others) for your wonderful generosity in helping patients with hemophilia, hemoglobinopathies or diabetes around the world.”
Stay updated with Hemostasis Today.
-
Apr 4, 2026, 18:08Anirban Sen Gupta: Dante Disharoon’s Research on PlateChek Featured on JTH April 2026 Cover
-
Apr 4, 2026, 18:06Domenico Girelli: WHO 2024 Guidelines Reveal Higher Global Anemia Burden and Epidemiological Shift
-
Apr 4, 2026, 18:04Fotios Barkas: Exploring The Bidirectional Relationship Between Frailty and Stroke
-
Apr 4, 2026, 17:56Marc Turner: VETERANSFirst, CHAMPION-AF Trial, and HI-PEITHO Trial Driving Innovation at ACC26
-
Apr 4, 2026, 17:55Julian Kyoung-Ryul Chun: The Largest Dataset on Embolic Complications after AF Is Out
-
Apr 4, 2026, 17:54Marie Dragoy: Insights from Norway on Helicopter Emergency Services in Suspected Stroke Care
-
Apr 4, 2026, 17:53Julia Shapranova: Connecting Neuroscience with The Reality of Clinical Trials Leadership and Management at ESOC 2026
-
Apr 4, 2026, 17:51Filippo Cademartiri: The DECIDE Registry Tackles a Critical Gap In Cardiovascular Care
-
Apr 4, 2026, 17:51Rabiah Alnoshan: A Pactical, Bedside Focused Approach to Bleeding